Akhil Alugupalli

Mr. Alugupalli is Partner at Alugupalli Venture Partners LLC, his family office. He has led angel investments into SpaceX, Robinhood, OcuTerra Therapeutics, and other private businesses. He led the Seed and Series A for SRIN Therapeutics Inc., as well as the Seed for POTUS Exploration Technologies Corporation, and is Chief Executive Officer and Chairman of the Board of Directors.

He received his biomedical research training at UPenn, Thomas Jefferson University, and the Rothman Institute. As a researcher, his background is in immunology and tumor biology, and is listed as an author of multiple scientific articles in peer-reviewed journals. He began his undergraduate career at Penn State as a Schreyer Scholar studying finance and bio-behavioral health.

In addition to founding SRIN, he heads day-to-day operations regarding corporate and pharmaceutical development within the SRIN pipeline.